Filing Details

Accession Number:
0000899243-16-033800
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-17 17:01:11
Reporting Period:
2016-11-16
Filing Date:
2016-11-17
Accepted Time:
2016-11-17 17:01:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1399529 Dicerna Pharmaceuticals Inc DRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274225 Dennis Langer C/O Dicerna Pharmaceuticals, Inc.
87 Cambridgepark Drive
Cambridge MA 02140
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-11-16 23,766 $3.52 71,428 No 4 S Indirect Langer Family Holdings, LLLP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Langer Family Holdings, LLLP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 43,595 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The reporting person disclaims beneficial ownership of the shares owned by Langer Family Holdings, LLLP.